Johnson & Johnson lost its motion on Wednesday to reverse a jury verdict that awarded $4.69 billion to women who blamed their ovarian cancer on asbestos in the company’s baby powder and other talc products. The plaintiffs — 22 women and their families — were the first to go to court against Johnson & Johnson claiming that their ovarian cancer was linked to asbestos contamination in the company’s talc. Documents used in the case and reported last week by The New York Times and Reuters revealed that Johnson & Johnson has known for decades about the risk of asbestos contamination in its talc, but fought to keep negative information behind closed doors. Mark Lanier, a lawyer for the women, said in a statement that his team was pleased with the order. Johnson & Johnson said that the verdict could still eventually be reversed in an appeals court.

Source: New York Times December 19, 2018 17:28 UTC